Cystic fibrosis: will the new biology deliver?

Hot topics
Chairs: J. Davies (London, United Kingdom), E. Kerem (Jerusalem, Israel)
Aims: The focus of the symposium is to present advances in cystic fibrosis research that provide exciting novel insights into the pathogenesis of cystic fibrosis. An excellent introduction in the basic biology of the disease as well as the bridge to common clinical practice in is of utmost importance and will be given by each of the talks of the symposium.

Cystic fibrosis: prospects for therapy of some class 1 mutations E. Kerem (Jerusalem, Israel)
Regulation of the response to stop mutation read-through by the nonsense mediated decay mechanism L. Linde (Jerusalem, Israel)
Replace the cells? Concepts and obstacles of stem cell therapy in cysticfibrosis C. Kaehler (Innsbruck, Austria)